DIA 48th Annual Meeting
Click here to go to the previous page
Pharma R&D in Asia: Opportunities, Models, and Challenges
Track
:
Track 03: Innovative Partnering Models and Outsourcing Strategies
Program Code:
155
Date:
Monday, June 25, 2012
Time:
3:30 PM to 5:00 PM
EST
CHAIR
:
Frank Flöther, Dr. Flöther Consulting, Switzerland
PRESENTER
(S):
Frank Flöther, Dr. Flöther Consulting, Switzerland Jack Xu, Shanghai Clinical Research Center (SCRC), China Young Jack Lee, LSK Global PS, Republic of Korea
Description
The center of the global pharmaceutical industry is shifting. Part of that shift is also the outsourcing of pharma R&D to Asia by various means and models. This symposium will highlight that strategic move in general but also discuss a clinical CRO alliance model and, furthermore, zoom into the Chinese clinical CRO business.
Learning Objectives:
Discuss the benefits, opportunities, and risks of doing Pharma R&D in Asia
Describe the advantages of regional CRO alliances versus multinational CROs in terms of cost effectiveness and efficiency of Asian regional clinical studies
Identify the challenges of clinical R&D in Chinese CROs.
Learning Objectives:
Discuss the benefits, opportunities, and risks of doing Pharma R&D in Asia
Describe the advantages of regional CRO alliances versus multinational CROs in terms of cost effectiveness and efficiency of Asian regional clinical studies
Identify the challenges of clinical R&D in Chinese CROs.
This session is a part of:
Handout Online
